2026 ICD-10-CM Diagnosis Code C02.4Malignant neoplasm of lingual tonsil
ICD-10-CM Codes›C00–D49›C00-C14›C02
- Billable — Valid for Submission
- Risk Adjusts — HCC 21
- Chronic Condition
C02.4 is a billable ICD-10-CM diagnosis code for malignant neoplasm of lingual tonsil. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 11 through 13, 146 through 148. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Head and neck cancers - lip and oral cavity.
For Medicare Advantage risk adjustment, C02.4 maps to CMS-HCC Category 21 (Lymphoma and Other Cancers) under the V28 model, adding a risk factor of about 0.671 for a community, non-dual, aged beneficiary in payment year 2026.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
C02.4 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.
Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Carcinoma of base of tongue
- Carcinoma of lingual tonsil
- Carcinoma of tongue base - dorsal surface
- Malignant neoplasm of base of tongue dorsal surface
- Malignant neoplasm of lingual tonsil
- Neoplasm of lingual tonsil
- Primary carcinoma of base of tongue
- Primary carcinoma of lingual tonsil
- Primary carcinoma of tongue base - dorsal surface
- Primary malignant neoplasm of base of tongue
- Primary malignant neoplasm of dorsal surface of tongue
- Primary malignant neoplasm of lingual tonsil
- Primary malignant neoplasm of Waldeyer's ring
- Primary squamous cell carcinoma of base of tongue
- Primary squamous cell carcinoma of dorsal surface of tongue
- Primary squamous cell carcinoma of lingual tonsil
- Primary squamous cell carcinoma of Waldeyer ring
- Primary tongue carcinoma
- Squamous cell carcinoma of tongue
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Type 2 Excludes
- malignant neoplasm of tonsil NOS C09.9
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Patient EducationClinical
Oral Cancer
Oral cancer is cancer of the mouth. It is a type of head and neck cancer. Most oral cancers are squamous cell cancers. They begin in the flat cells that cover the surfaces of your mouth, tongue, and lips. The cancer cells may spread into deeper tissue as the cancer grows.
The full article covers:
- What is oral cancer?
- Who is more likely to develop oral cancer?
- What are the symptoms of oral cancer?
- How is oral cancer diagnosed?
- What are the treatments for oral cancer?
- Can oral cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C02.4 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C02.4Overview
What is the ICD-10 code for malignant neoplasm of lingual tonsil?
The ICD-10-CM code for malignant neoplasm of lingual tonsil is C02.4 (sometimes written as C024). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is C02.4 (Malignant neoplasm of other and unspecified parts of tongue) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of lingual tonsil on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C02.4 group to?
When malignant neoplasm of lingual tonsil is the principal diagnosis on an inpatient stay, it groups to MS-DRG 11, 12, 13, 146, 147, 148, with relative weights from 0.7971 to 5.4541 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C02.4?
Under the General Equivalence Mappings, malignant neoplasm of lingual tonsil converts to ICD-9-CM 141.6 (mal neo lingual tonsil). The mapping is a direct match.
What HCC is C02.4?
C02.4 (malignant neoplasm of lingual tonsil) maps to CMS-HCC Category 21 (Lymphoma and Other Cancers), commonly written as HCC 21, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 11 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 22.
Does C02.4 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, C02.4 adds a risk adjustment factor of about 0.671 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.493 to 0.739 depending on the payment segment). A more severe related category (HCC 17, HCC 18, HCC 19, and HCC 20) supersedes it when both are reported. See the full factor table on the HCC 21 category page.
